Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
Dear Cancer Coach- I am 47 and was diagnosed with Multiple Myeloma in August 2014. I started chemo, had a great response and went into remission very quickly. I had tandem stem cell transplants. The first one was in January and the second was in April. I did well above average with both and I feel amazing.
I saw my doctor today who is suggesting that I go on revlimid for maintenance therapy and I have to say that I really don’t want to. I’ve been extremely optimistic throughout this and am looking for suggestions, ideas or anything that might be helpful moving forward. I am a vegetarian and generally eat pretty healthy and I recently started exercising again.
I look forward to hearing more from you.
Thank you so much,
I am sorry to read of your MM diagnosis. However you seem to be doing well. It is great to read that you are feeling well after your tandem transplants.
To answer your question:
“I saw my doctor today who is suggesting that I go on revlimid for maintenance therapy and I have to say that I really don’t want to. I’ve been extremely optimistic throughout this and am looking for suggestions, ideas or anything that might be helpful moving forward…”
I belong to several MM forums and the issue of maintenance therapy, 5 mg or 10mg of revilmid daily, is frequently debated. Many MMers are being encouraged to go on maintenance therapy. I have read that studies exist that say MMers live longer, on average, with maint. therapy. I have not read any study to this effect. I believe that toxicity should be avoided, especially after induction therapy and a tandem stem cell transplant.
Reanne, you are in charge of your MM and your therapies. People like me or your onc. can only make recommendations. I believe that evidence-based nutritional supplementation reduces the risk of MM relapse without the toxicity.
Please watch the video below to learn more about the evidence-based, integrative therapies to combat treatment side effects and enhance your chemotherapy.
I will link the studies about MM and curcumin, resveratrol, omega 3 fatty acids and green tea extract below.
I supplement with each of these daily- I am happy to link what I take-
Let me know if you have any questions.
“Based on a review of these studies, it is evident that better bioavailability of formulated curcumin (CU) products is mostly attributed to improved solubility, stability, and possibly low first-pass metabolism”
A search of the Pubmed database for the word curcumin yields 601 studies spaning health topics from multiple myeloma and colorectal cancer, to chemotherapies that synergizes with CU, to Alzheimer’s Disease, arthritis and more. Based on years of reading studies and personal accounts, I think it is safe to say that CU supplementation is safe and relatively inexpensive.
I have read about myeloma patients taking daily doses of CU from 400 milligrams to 8 grams (1000 milligrams = 1 gram). By almost any measure, CU is a safe, inexpensive wonder drug.
The only challenge is that CU is famously difficult to absorb in the body. In other words, a person has to mix curcumin with some sort of fat (coconut oil, chocolate, etc.) or take a brand of curcumin capsule that is already formulated to be more “bioavailable” in order to derive the full benefit of CU.
The study linked and exerpted below reviews different formulations of CU. The study itself lists the three most bioavailable formulation/brand of CU and I’ve added an excerpt from a further review from Consumerlab.com that lists four additional bioavailable brands of CU.
I consult the independent evaluation service Consumerlab.com frequently. For one low annual payment, I can read about and evaluate all of the nutritional supplement that I take.
“CU is a bright yellow chemical produced by some plants. It is the principal curcuminoid of turmeric (Curcuma longa), a member of the ginger family, Zingiberaceae. It is sold as an herbal supplement, cosmetics ingredient, food flavoring, and food coloring.“
“Curcumin is a widely studied natural compound which has shown tremendous in vitro therapeutic potential. Despite that, the clinical efficacy of the native CU is weak due to its low bioavailability and high metabolism in the gastrointestinal tract. During the last decade, researchers have come up with different formulations with a focus on improving the bioavailability of curcumin. As a result, a significant number of bioavailable curcumin-based formulations were introduced with the varying range of enhanced bioavailability.
The purpose of this review is to collate the published clinical studies of CU products with improved bioavailability over conventional (unformulated) CU. Based on the literature search, 11 curcumin formulations with available human bioavailability and pharmacokinetics data were included in this review. Further, the data on clinical study design, analytical method, pharmacokinetic parameters and other relevant details of each formulation were extracted.
Based on a review of these studies, it is evident that better bioavailability of formulated curcumin products is mostly attributed to improved solubility, stability, and possibly low first-pass metabolism. The review hopes to provide a quick reference guide for anyone looking information on these bioavailable curcumin formulations.
Based on the published reports,
exhibited over 100-fold higher bioavailability relative to reference unformulated CU. Suggested mechanisms accounting for improved bioavailability of the formulations and details on the bioanalysis methods are also discussed.”
According to Consumerlab.com:
“Novasol has the highest bioavailability (185 x compared to unforumulated CU), followed by Curcuwin (136 x), Longvida (100 x), Meriva (48 x), BCM-95 (27 x), Curcumin C3 Complex + Bioperene (20 x), and then Theracumin (16 x).”